---
title: "HTRA2"
date: 2023-05-13 00:00:00
layout: post
categories: Gene
summary: "# Gene HTRA2"
tags: ['GeneHTRA2', 'ParkinsonsDisease', 'MitochondrialQualityControl', 'Prognosis', 'DrugResponse', 'SNVs', 'dbSNP', 'ResearchPapers']
---

# Gene HTRA2

## Information

- **Genetic position:** Chromosome 2 (2p12-p11.2)
- **Pathology:** HTRA2 is associated with Parkinson's disease
- **Function for gene:** HTRA2 encodes a protein called high-temperature requirement A2, which is involved in both the ubiquitin-proteasome system and mitochondrial quality control.
- **Aliases:** OMI, PARK13, PRSS25
- **External IDs:**
    - HGNC: 19739
    - NCBI Entrez: 27429
    - Ensembl: ENSG00000115549
    - OMIM: 605997
    - UniProtKB/Swiss-Prot: O43464
- **AA mutation list and mutation type with dbSNP ID:** There are various amino acid (AA) mutations listed on dbSNP for HTRA2, including:
    - p.Thr119Met (rs1130161)
    - p.Pro171Leu (rs139428292)
    - p.Arg274Trp (rs111716904)
- **Somatic SNVs/InDels with dbSNP ID:** There are several somatic SNVs listed on dbSNP for HTRA2, including:
    - rs17258213
    - rs17258214
- **Related Disease:** Parkinson's disease
- **Treatment and prognosis:** Treatment for Parkinson's disease is primarily focused on managing symptoms and improving quality of life. Prognosis varies depending on the individual and the progression of the disease.
- **Drug response:** There are various drugs used in the treatment of Parkinson's disease, including levodopa, dopamine agonists, and MAO-B inhibitors.
- **Subject, author name, DOI links to related papers:**

   - Subject: The role of HTRA2 mutations in Parkinson's disease
   - Author: Strauss KM et al.
   - DOI: 10.1016/j.jns.2005.04.012

   - Subject: Association between HTRA2 and Parkinson's disease
   - Author: Martin I et al.
   - DOI: 10.1126/science.1114397

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**